SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-347766
Filing Date
2018-12-12
Accepted
2018-12-12 16:15:36
Documents
6
Period of Report
2018-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d658797d8k.htm 8-K 19109
2 EX-1.1 d658797dex11.htm EX-1.1 158311
3 EX-5.1 d658797dex51.htm EX-5.1 6514
4 EX-99.1 d658797dex991.htm EX-99.1 9513
5 EX-99.2 d658797dex992.htm EX-99.2 10484
6 GRAPHIC g658797g1211141543652.jpg GRAPHIC 2744
  Complete submission text file 0001193125-18-347766.txt   209046
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 181231045
SIC: 2834 Pharmaceutical Preparations